{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:59:52Z","timestamp":1790837992128,"version":"4.1.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>The chronic use of immunosuppressive drugs is a key risk factor of death because of coronavirus disease 2019 (COVID-19) in kidney transplant recipients (KTRs), although no evident association between the class of immunosuppressive and outcomes has been observed. Thus, we aimed to compare COVID-19\u2013associated outcomes among KTRs receiving 3 different immunosuppressive maintenance regimes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>This study included data from 1833 KTRs with COVID-19 diagnosed between March 20 and April 21 extracted from the national registry before immunization. All patients were taking calcineurin inhibitor associated with mycophenolate acid (MPA, n = 1258), azathioprine (AZA, n = 389), or mammalian targets of rapamycin inhibitors (mTORi, n = 186). Outcomes within 30 and 90 d were assessed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Compared with patients receiving MPA, the 30-d (79.9% versus 87.9% versus 89.2%; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.0001) and 90-d (75% versus 83.5% versus 88.2%; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.0001) unadjusted patient survivals were higher in those receiving AZA or mTORi, respectively. Using adjusted multivariable Cox regression, compared with patients receiving AZA, the use of MPA was associated with a higher risk of death within 30 d (adjusted hazard ratio [aHR], 1.70; 95% confidence interval [CI], 1.21-2.40; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.003), which was not observed in patients using mTORi (aHR, 0.78; 95% CI, 0.45-1.35; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.365). At 90 d, although higher risk of death was confirmed in patients receiving MPA (aHR, 1.46; 95% CI, 1.09-1.98; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.013), a reduced risk was observed in patients receiving mTORi (aHR, 0.59; 95% CI, 0.35-0.97; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.04) compared with AZA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>This national cohort data suggest that, in KTRs receiving calcineurin inhibitor and diagnosed with COVID-19, the use of MPA was associated with higher risk of death, whereas mTORi use was associated with lower risk of death.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000004251","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T04:01:45Z","timestamp":1656475305000},"page":"e441-e451","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["The Mycophenolate-based Immunosuppressive Regimen Is Associated With Increased Mortality in Kidney Transplant Patients With COVID-19"],"prefix":"10.1097","volume":"106","author":[{"given":"L\u00facio R.","family":"Requi\u00e3o-Moura","sequence":"first","affiliation":[{"name":"Nephrology Division, Department of Medicine, Federal University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil."},{"name":"Department of Transplantation, Hospital do Rim, Funda\u00e7\u00e3o Oswaldo Ramos, S\u00e3o Paulo, Brazil."},{"name":"Renal Transplant Unit, Hospital Israelita Albert Einstein, S\u00e3o Paulo, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds Gustavo","family":"Modelli de Andrade","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Universidade Estadual Paulista-UNESP, Botucatu, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tain\u00e1 Veras","family":"de Sandes-Freitas","sequence":"additional","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias M\u00e9dicas, Departamento de Medicina Cl\u00ednica, Faculdade de Medicina, Universidade Federal do Cear\u00e1, Fortaleza, Brazil."},{"name":"Hospital Universit\u00e1rio Walter Cant\u00eddio, Fortaleza, Brazil."},{"name":"Hospital Geral de Fortaleza, Fortaleza, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Pontello","family":"Cristelli","sequence":"additional","affiliation":[{"name":"Department of Transplantation, Hospital do Rim, Funda\u00e7\u00e3o Oswaldo Ramos, S\u00e3o Paulo, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila Almeida","family":"Viana","sequence":"additional","affiliation":[{"name":"Department of Transplantation, Hospital do Rim, Funda\u00e7\u00e3o Oswaldo Ramos, S\u00e3o Paulo, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f4nica Rika","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Transplantation, Hospital do Rim, Funda\u00e7\u00e3o Oswaldo Ramos, S\u00e3o Paulo, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valter Duro","family":"Garcia","sequence":"additional","affiliation":[{"name":"Santa Casa de Miseric\u00f3rdia de Porto Alegre, Porto Alegre, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto Ceratti","family":"Manfro","sequence":"additional","affiliation":[{"name":"Hospital de Cl\u00ednicas de Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise Rodrigues","family":"Sim\u00e3o","sequence":"additional","affiliation":[{"name":"Hospital Santa Isabel, Blumenau, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Augusto Monteiro de Barros","family":"Almeida","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Universidade Estadual Paulista-UNESP, Botucatu, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo Fernandes","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Santa Casa de Miseric\u00f3rdia de Juiz de Fora, Juiz de Fora, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kellen Micheline Alves Henrique","family":"Costa","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Kidney Transplantation, Onofre Lopes University Hospital, Natal, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Roberta","family":"de Lima","sequence":"additional","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias M\u00e9dicas, Departamento de Medicina Cl\u00ednica, Faculdade de Medicina, Universidade Federal do Cear\u00e1, Fortaleza, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Pacheco-Silva","sequence":"additional","affiliation":[{"name":"Renal Transplant Unit, Hospital Israelita Albert Einstein, S\u00e3o Paulo, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida Maria Maximina Fernandes","family":"Charpiot","sequence":"additional","affiliation":[{"name":"Hospital de Base, Medical School FAMERP, S\u00e3o Jos\u00e9 do Rio Preto, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciane M\u00f4nica","family":"Deboni","sequence":"additional","affiliation":[{"name":"Hospital Municipal S\u00e3o Jos\u00e9 (HMSJ), Joinville, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa Cristina Alves","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Hospital Universit\u00e1rio da UFMA, S\u00e3o Luis, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilda","family":"Mazzali","sequence":"additional","affiliation":[{"name":"Renal Transplant Research Laboratory, Renal Transplant Unit, Division of Nephrology, School of Medical Sciences, University of Campinas \u2013 UNICAMP, Campinas, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Alberto Chalabi","family":"Calazans","sequence":"additional","affiliation":[{"name":"Hospital Marcio Cunha, Ipatinga, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinaldo Barreto","family":"Ori\u00e1","sequence":"additional","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias M\u00e9dicas, Departamento de Medicina Cl\u00ednica, Faculdade de Medicina, Universidade Federal do Cear\u00e1, Fortaleza, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9lio","family":"Tedesco-Silva","sequence":"additional","affiliation":[{"name":"Nephrology Division, Department of Medicine, Federal University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil."},{"name":"Department of Transplantation, Hospital do Rim, Funda\u00e7\u00e3o Oswaldo Ramos, S\u00e3o Paulo, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Medina-Pestana","sequence":"additional","affiliation":[{"name":"Nephrology Division, Department of Medicine, Federal University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil."},{"name":"Department of Transplantation, Hospital do Rim, Funda\u00e7\u00e3o Oswaldo Ramos, S\u00e3o Paulo, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the COVID-19-KT Brazil Study Group*","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"issue":"Suppl 2","key":"R1-20250604","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.2215\/CJN.02900707","article-title":"Viral infection after renal transplantation: surveillance and management.","volume":"3","author":"Weikert","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/TP.0000000000003523","article-title":"COVID-19 and solid organ transplantation: a review article.","volume":"105","author":"Azzi","year":"2021","journal-title":"Transplantation"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1056\/NEJMc2011117","article-title":"COVID-19 and kidney transplantation.","volume":"382","author":"Akalin","year":"2020","journal-title":"N Engl J Med"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1111\/ajt.16185","article-title":"COVID-19 and kidney transplantation: results from the TANGO International Transplant Consortium.","volume":"20","author":"Cravedi","year":"2020","journal-title":"Am J Transplant"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"e0254822","DOI":"10.1371\/journal.pone.0254822","article-title":"High mortality among kidney transplant recipients diagnosed with coronavirus disease 2019: results from the Brazilian multicenter cohort study.","volume":"16","author":"Requi\u00e3o-Moura","year":"2021","journal-title":"PLoS One"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/ajt.16416","article-title":"COVID-19 severity in kidney transplant recipients is similar to nontransplant patients with similar comorbidities.","volume":"21","author":"Chavarot","year":"2021","journal-title":"Am J Transplant"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1111\/ajt.16280","article-title":"Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States.","volume":"20","author":"Molnar","year":"2020","journal-title":"Am J Transplant"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s40620-021-01172-1","article-title":"Comparison of 30-day case-fatality rate between dialysis and transplant COVID-19 patients: a propensity score matched cohort study.","volume":"35","author":"de Sandes-Freitas","year":"2022","journal-title":"J Nephrol"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/TP.0b013e3181952623","article-title":"Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review.","volume":"87","author":"Knight","year":"2009","journal-title":"Transplantation"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1681\/ASN.2018010009","article-title":"Everolimus with reduced calcineurin inhibitor exposure in renal transplantation.","volume":"29","author":"Pascual","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0140-6736(04)16808-6","article-title":"Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial.","volume":"364","author":"Remuzzi","year":"2004","journal-title":"Lancet"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00007890-199604150-00008","article-title":"A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.","volume":"61","year":"1996","journal-title":"Transplantation"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1034\/j.1399-0012.2000.140206.x","article-title":"Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients.","volume":"14","author":"Sarmiento","year":"2000","journal-title":"Clin Transplant"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1111\/ajt.13327","article-title":"Reduced incidence of cytomegalovirus infection in kidney transplant recipients receiving everolimus and reduced tacrolimus doses.","volume":"15","author":"Tedesco-Silva","year":"2015","journal-title":"Am J Transplant"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1097\/TP.0000000000002626","article-title":"Safety of everolimus with reduced calcineurin inhibitor exposure in de novo kidney transplants: an analysis from the randomized TRANSFORM study.","volume":"103","author":"Tedesco-Silva","year":"2019","journal-title":"Transplantation"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"e13267","DOI":"10.1111\/tid.13267","article-title":"Infections after kidney transplantation: a comparison of mTOR-Is and CNIs as basic immunosuppressants. A systematic review and meta-analysis.","volume":"22","author":"Wolf","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/TP.0b013e3182708e56","article-title":"Is cytomegalovirus prophylaxis dispensable in patients receiving an mTOR inhibitor-based immunosuppression? A systematic review and meta-analysis.","volume":"94","author":"Andrassy","year":"2012","journal-title":"Transplantation"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/TP.0b013e318276a1ef","article-title":"Everolimus-treated renal transplant recipients have a more robust CMV-specific CD8+ T-cell response compared with cyclosporine- or mycophenolate-treated patients.","volume":"95","author":"Havenith","year":"2013","journal-title":"Transplantation"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1681\/ASN.2020121753","article-title":"mTOR inhibitors prevent CMV infection through the restoration of functional \u03b1\u03b2 and \u03b3\u03b4 T cells in kidney transplantation.","volume":"33","author":"Kaminski","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1097\/TP.0b013e3181fc09fe","article-title":"Pandemic influenza A\/H1N1 virus infection in solid organ transplant recipients: a multicenter study.","volume":"90","author":"Smud","year":"2010","journal-title":"Transplantation"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/S2665-9913(21)00325-8","article-title":"Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative.","volume":"4","author":"Andersen","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/ajt.16807","article-title":"Development and validation of a simple web-based tool for early prediction of COVID-19-associated death in kidney transplant recipients.","volume":"22","author":"Modelli de Andrade","year":"2022","journal-title":"Am J Transplant"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate.","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1080\/22221751.2020.1799723","article-title":"Dysregulation in Akt\/mTOR\/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells.","volume":"9","author":"Appelberg","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1128\/AAC.03659-14","article-title":"Antiviral potential of ERK\/MAPK and PI3K\/AKT\/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis.","volume":"59","author":"Kindrachuk","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/jmv.26009","article-title":"Immunoregulation with mTOR inhibitors to prevent COVID-19 severity: a novel intervention strategy beyond vaccines and specific antiviral medicines.","volume":"92","author":"Zheng","year":"2020","journal-title":"J Med Virol"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2666-7568(20)30068-4","article-title":"The potential of rapalogs to enhance resilience against SARS-CoV-2 infection and reduce the severity of COVID-19.","volume":"2","author":"Bischof","year":"2021","journal-title":"Lancet Healthy Longev"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"108464","DOI":"10.1016\/j.clim.2020.108464","article-title":"Targeting T-cell senescence and cytokine storm with rapamycin to prevent severe progression in COVID-19.","volume":"216","author":"Omarjee","year":"2020","journal-title":"Clin Immunol"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/CCM.0b013e3182a2727d","article-title":"Adjuvant treatment with a mammalian target of rapamycin inhibitor, sirolimus, and steroids improves outcomes in patients with severe H1N1 pneumonia and acute respiratory failure.","volume":"42","author":"Wang","year":"2014","journal-title":"Crit Care Med"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jhep.2020.07.040","article-title":"Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients.","volume":"74","author":"Colmenero","year":"2021","journal-title":"J Hepatol"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1007\/s00125-020-05180-x","article-title":"Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study.","volume":"63","author":"Cariou","year":"2020","journal-title":"Diabetologia"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4269\/ajtmh.20-0375","article-title":"Metformin treatment was associated with decreased mortality in COVID-19 patients with diabetes in a retrospective analysis.","volume":"103","author":"Luo","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"R33-20250604","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/jmv.26498","article-title":"Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: a meta-analysis.","volume":"93","author":"Kow","year":"2021","journal-title":"J Med Virol"},{"key":"R34-20250604","doi-asserted-by":"crossref","first-page":"e13595","DOI":"10.1111\/tid.13595","article-title":"Effect of immunosuppression maintenance in solid organ transplant recipients with COVID-19: systematic review and meta-analysis.","volume":"23","author":"Karruli","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"R35-20250604","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/TP.0000000000004059","article-title":"Real-world effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S vaccines against SARS-CoV-2 in solid organ and islet transplant recipients.","volume":"106","author":"Callaghan","year":"2022","journal-title":"Transplantation"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004251","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T19:00:15Z","timestamp":1749063615000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004251","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,29]]}}}